Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00139867 |
Date of registration:
|
29/08/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
|
Scientific title:
|
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease |
Date of first enrolment:
|
January 2004 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00139867 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
UCB Clinical Trial Call Center |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
UCB Pharma |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Stable Parkinson's Disease
Exclusion Criteria:
- Not using carbidopa/levodopa tablets
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Parkinson's Disease
|
Intervention(s)
|
Drug: PARCOPA
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|